What are the recommended strategies for setting the maximum pressure (pMax) in complex non‑invasive ventilation using average volume‑assured pressure support (AVAPS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

AVAPS pMax Setting Strategy

For AVAPS (Average Volume-Assured Pressure Support) mode, set IPAPmax at 25-30 cm H₂O for adults ≥12 years and 20 cm H₂O for children <12 years, with IPAPmin at EPAP + 4 cm H₂O and EPAP starting at 4 cm H₂O. 1

Initial AVAPS Settings

The American Academy of Sleep Medicine consensus guidelines provide clear starting parameters for volume-targeted BPAP (AVAPS):

  • EPAP: 4 cm H₂O (lowest available on most devices)
  • IPAPmin: EPAP + 4 cm H₂O (typically 8 cm H₂O initially)
  • IPAPmax: 25-30 cm H₂O for patients ≥12 years; 20 cm H₂O for patients <12 years
  • Target tidal volume: ~8 mL/kg ideal body weight 1

Rationale for pMax Selection

The IPAPmax setting creates the upper boundary within which the device automatically adjusts pressure support to deliver the target tidal volume. Setting IPAPmax at 25-30 cm H₂O allows sufficient range for the device to compensate for declining respiratory muscle strength, increased airway resistance, or changing sleep stages while maintaining adequate ventilation. 1

The maximum IPAP of 30 cm H₂O represents the upper limit available on most NPPV devices and aligns with safety parameters established for adult patients. The lower 20 cm H₂O maximum for pediatric patients (<12 years) reflects reduced tolerance and different physiological requirements in this population. 1

Adjusting EPAP Within AVAPS

While IPAPmax defines the upper pressure limit, EPAP must be titrated independently to eliminate obstructive events (apneas, hypopneas, RERAs, snoring) following standard CPAP titration protocols. 1 The device then automatically varies IPAP between IPAPmin and IPAPmax to maintain target tidal volume.

Clinical Context and Mode Selection

AVAPS represents an acceptable alternative to fixed-level pressure support, particularly when:

  • Respiratory muscle strength fluctuates during sleep
  • Tidal volumes are inconsistent on fixed BiPAP
  • Automatic adjustment is desired to maintain consistent minute ventilation 1

However, current evidence shows AVAPS achieves equivalent outcomes to properly titrated fixed-level pressure support in most conditions including obesity hypoventilation syndrome 2, acute hypercapnic respiratory failure 3, and COPD 4. The faster CO₂ correction seen with AVAPS in some acute settings 4 has not translated to improved survival or reduced intubation rates across most studies 3, 5.

Backup Rate and Inspiratory Time

When using AVAPS in spontaneous-timed (ST) or timed modes:

  • Backup rate: Set at or slightly below spontaneous sleeping respiratory rate (minimum 10 bpm)
  • Inspiratory time: 30-40% of cycle time (e.g., 1.2-1.6 seconds at 15 breaths/min)
  • Adjust I:E ratio based on underlying pathology: lower for obstructive disease (longer expiration), higher for restrictive disease (longer inspiration) 1

Common Pitfalls

Avoid setting IPAPmax too low (<20 cm H₂O in adults), as this restricts the device's ability to deliver adequate pressure support when needed, essentially negating the advantage of volume-assured ventilation. Conversely, while 30 cm H₂O is the recommended maximum, patient comfort and tolerance should guide final settings—if patients consistently awaken complaining of excessive pressure, reduce to tolerable levels even if below optimal targets. 1

The target tidal volume of 8 mL/kg may need adjustment: slightly lower tidal volumes (6-7 mL/kg) with higher respiratory rates may improve tolerance in individual patients, particularly those with obstructive lung disease. 1

Related Questions

What AVAPS (average volume-assured pressure support) settings should be used for an adult who is 66 inches (≈5 ft 6 in) tall?
Can average volume‑assured pressure support (AVAPS) be described as a complicated form of non‑invasive ventilation (NIV)?
What is the differential diagnosis for a 16-year-old female presenting with multiple vesicular lesions on both the upper and lower lips?
Is a blood pressure of 96/59 mm Hg normal for a 14‑year‑old adolescent?
What management is recommended for a blood pressure of 135/83 mm Hg?
How well is buspirone tolerated in an 83-year-old mobile elderly patient?
What are the contraindications to initiating cholesterol‑lowering therapy (e.g., statins)?
Which bipolar disorder medications are safe to use in patients with a seizure disorder, and which agents should be avoided?
How should a 16-year-old female with three months of progressive low back pain, midline bony tenderness from L3 to L5, paraspinal muscle tenderness, calf cramping with straight‑leg raise, normal strength, no paresthesias or bowel/bladder changes, pain worsened by flexion or rotation and improved when lying down, and a past history of pilonidal disease be evaluated and managed?
How should a patient on methotrexate be managed if they develop decreased renal function, including dosing adjustments and when to discontinue the drug?
What is the best‑supported medication for a patient with co‑occurring Tourette syndrome and a history of major depressive disorder (moderate), generalized anxiety disorder, social anxiety disorder, panic attacks, and intellectual disability?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.